Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology

被引：16
|
作者：
Nishiyama, Yuki [1 ]
Koya, Toshiyuki [1 ]
Nagano, Kei [1 ]
Abe, Seitaro [1 ]
Kimura, Yosuke [1 ]
Shima, Kenjiro [1 ]
Toyama-Kosaka, Mio [1 ]
Hasegawa, Takashi [2 ]
Sasaki, Takanobu [3 ]
Shinbori, Kaori [3 ]
Ueki, Shigeharu [4 ]
Takamura, Kaori [5 ]
Kikuchi, Toshiaki [1 ]
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, 1-757 Asahimachi Dori,Chuo Ku, Niigata, Niigata 9518510, Japan
[2] Niigata Univ, Med & Dent Hosp, Dept Gen Med, Niigata, Japan
[3] Niigata Univ, Grad Sch Med & Dent Sci, Dept Otolaryngol Head & Neck Surg, Niigata, Japan
[4] Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita, Japan
[5] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan
来源：
ALLERGOLOGY INTERNATIONAL | 2022年 / 71卷 / 04期
关键词：
D O I：
10.1016/j.alit.2022.03.005
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：548 / 551
页数：4
相关论文
共 50 条
  • [41] Global influence of dupilumab on Quality of Life in a severe asthma patient with T2 multimorbidities: a case report on atopic dermatitis, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis
    Colque-Bayona, Monica
    Hernandez-Cano, Natalia
    Tomas-Perez, Margarita
    Caballero, Teresa
    Quirce, Santiago
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA, 2024, 61 (07) : 762 - 765
  • [42] Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab
    Suzaki, Isao
    Kimura, Yurika
    Tanaka, Akihiko
    Hirano, Kojiro
    Ishibashi, Atsushi
    Mizuyoshi, Tomomi
    Ando, Izumi
    Kitajima, Tatsuya
    Watanabe, So
    Hinohira, Yasuyuki
    Kobayashi, Hitome
    AURIS NASUS LARYNX, 2019, 46 (01) : 141 - 146
  • [43] Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases
    Romano, Ciro
    Cozzolino, Domenico
    Sellitto, Ausilia
    Rinaldi, Luca
    APPLIED SCIENCES-BASEL, 2022, 12 (22):
  • [44] Gαi1/3 signaling mediates IL-5-induced eosinophil activation and type 2 inflammation in eosinophilic chronic rhinosinusitis
    Xie, Huanxia
    Ji, Jiang
    Lu, Ning
    Liu, Zhichen
    Wei, Yuqian
    Zhou, Aina
    Liu, Jisheng
    Jiao, Qingqing
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [45] Severe Asthma or Chronic Obstructive Pulmonary Disease with Eosinophilic Inflammation? From Uncertainty to Remission under Anti IL-5R Therapy
    Oprescu, Bianca
    Raduna, Oana
    Mihaicuta, Stefan
    Frent, Stefan
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [46] Late Breaking Abstract - Anti-IL-5 therapy is associated with sustained improvement in FEV1 in severe eosinophilic asthma patients.
    Blekic, Nathan
    Van Muylem, Alain
    Makhoul, Jean-Pierre
    Haccuria, Amaryllis
    Malinovschi, Andrei
    Michils, Alain
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [47] A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis
    Takabayashi, Tetsuji
    Asaka, Daiya
    Okamoto, Yoshitaka
    Himi, Tetsuo
    Haruna, Shinichi
    Yoshida, Naohiro
    Kondo, Kenji
    Yoshikawa, Mamoru
    Sakuma, Yasunori
    Shibata, Kunihiko
    Suzuki, Motohiko
    Kobayashi, Masayoshi
    Kawata, Ryo
    Tsuzuki, Kenzo
    Okano, Mitsuhiro
    Higaki, Takaya
    Takeno, Sachio
    Kodama, Satoru
    Yonekura, Syuji
    Saito, Hiromi
    Nozaki, Akiyo
    Otori, Nobuyoshi
    Fujieda, Shigeharu
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2021, 35 (06) : 861 - 870
  • [48] Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
    Kroes, Johannes A.
    Zielhuis, Sybrand W. J.
    De Jong, Kim
    Zielhuis, Sander W.
    Van Roon, Eric N.
    Bel, Elisabeth H. D.
    Ten Brinke, Anneke
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus
    Burgstaller, S.
    Kreil, S.
    Waghorn, K.
    Metzgeroth, G.
    Preudhomme, C.
    Zoi, K.
    White, H.
    Cilloni, D.
    Zoi, C.
    Brito-Babapulle, F.
    Walz, C.
    Reiter, A.
    Cross, N. C. P.
    LEUKEMIA, 2007, 21 (12) : 2428 - 2432
  • [50] The severity of FIP1L1–PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus
    S Burgstaller
    S Kreil
    K Waghorn
    G Metzgeroth
    C Preudhomme
    K Zoi
    H White
    D Cilloni
    C Zoi
    F Brito-Babapulle
    C Walz
    A Reiter
    N C P Cross
    Leukemia, 2007, 21 : 2428 - 2432
12345